CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I, Single-center, Randomized, Double-blind, Single-dose, Parallel Comparison of Pharmacokinetic and Safety Similarities Between Meperizumab Injection and NUCALA® in Healthy Male Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05353179
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:41.039384+00:00
Published At: 2022-04-29T00:00:00+00:00
Record Updated At: 2022-04-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Granulomatosis With Polyangiitis", "Hemophagocytic Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-29"
protocolSection.identificationModule.nctId: "NCT05353179"
protocolSection.identificationModule.officialTitle: "Phase I, Single-center, Randomized, Double-blind, Single-dose, Parallel Comparison of Pharmacokinetic and Safety Similarities Between Meperizumab Injection and NUCALA\u00ae in Healthy Male Volunteers"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.